Based on the Hadasit Bio-Holdings Ltd stock forecast from 0 analysts, the average analyst target price for Hadasit Bio-Holdings Ltd is not available over the next 12 months. Hadasit Bio-Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Hadasit Bio-Holdings Ltd is Slightly Bearish, which is based on 4 positive signals and 5 negative signals. At the last closing, Hadasit Bio-Holdings Ltd’s stock price was USD 0.13. Hadasit Bio-Holdings Ltd’s stock price has changed by +0.00% over the past week, +1.38% over the past month and -47.28% over the last year.
No recent analyst target price found for Hadasit Bio-Holdings Ltd
No recent average analyst rating found for Hadasit Bio-Holdings Ltd
Company Overview Hadasit Bio-Holdings Ltd
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel. Read Less
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an im...Read More
Frequently Asked Questions About Hadasit Bio-Holdings Ltd (HSITF) Stock
Stock Target Advisor's fundamental analysis for Hadasit Bio-Holdings Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on HSITF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on HSITF's stock to indicate what its average analyst target is.
HSITF stock's Price/Earning ratio is 0.57.
Our analysis grades HSITF stock's Price / Earning ratio at B. This means that HSITF stock's Price/Earning ratio is above 15% of the stocks in the Biotechnology sector in the OTC exchange.
Based on this HSITF may be undervalued for its sector.
The last closing price of HSITF's stock was USD 0.13.
The most recent market capitalization for HSITF is USD 1.59M.
Unfortunately we do not have enough analyst data on HSITF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Hadasit Bio-Holdings Ltd's stock.
As per our most recent records Hadasit Bio-Holdings Ltd has 0 Employees.
Hadasit Bio-Holdings Ltd's registered address is Jerusalem Bio-Park, Jerusalem, Israel, 91120.
You can get more information about it from Hadasit Bio-Holdings Ltd's website at https://www.hbl.co.il.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Hadasit Bio-Holdings Ltd (HSITF) Stock
Stock Target Advisor's fundamental analysis for Hadasit Bio-Holdings Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on HSITF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on HSITF's stock to indicate what its average analyst target is.
HSITF stock's Price/Earning ratio is 0.57.
Our analysis grades HSITF stock's Price / Earning ratio at B. This means that HSITF stock's Price/Earning ratio is above 15% of the stocks in the Biotechnology sector in the OTC exchange.
Based on this HSITF may be undervalued for its sector.
The last closing price of HSITF's stock was USD 0.13.
The most recent market capitalization for HSITF is USD 1.59M.
Unfortunately we do not have enough analyst data on HSITF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Hadasit Bio-Holdings Ltd's stock.
As per our most recent records Hadasit Bio-Holdings Ltd has 0 Employees.
Hadasit Bio-Holdings Ltd's registered address is Jerusalem Bio-Park, Jerusalem, Israel, 91120.
You can get more information about it from Hadasit Bio-Holdings Ltd's website at https://www.hbl.co.il.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HSITF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
